Dwarfism (DWF)
Gene or Region: ACAN, B4GALT7
Reference Variant: Various
Mutant Variant: Various
Affected Breeds: Many
Research Confidence: High - Strong association in studied population
Explanation of Results: DWF/DWF = homozygous for Dwarfism, trait expressed DWF/n = heterozygous for Dwarfism, carrier n/n = no variant detected
General Description for Dwarfism
Dwarfism is characterized by abnormal growth, leading to either a disproportionate body type or overall smaller body size. There are many variants for Dwarfism including, but not limited to, ACAN 1-5 (originally found in miniature horses, and Shetland ponies), and B4GALT7 (originally founded in Friesian horses). Dwarfism caused by mutations in the Aggrecan gene (ACAN) results in a dwarf foal with a wide range of physical ailments and limitations. Dwarf horses often have breathing problems, eating difficulties, and other health issues related to their abnormal bone growth. Other unrelated causes of Dwarfism are skeletal atavism, and osteochondrodysplasia which are not a result of the ACAN mutations. Specifically in the Friesian, the limbs and ribs are mainly affected, leading to a normal sized head, disproportionate back, and abnormally short legs. Research has indicated that it is inherited in an autosomal recessive manner. A recent study also indicated that horses with one variant may be 20% smaller than their ACAN negative relatives.
A single genome-wide association study of 10 dwarfs and 10 full-sized Friesians failed to identify a candidate gene or mutation. The tested SNP had the strongest association within this study, though the researchers did not report which allele was linked to the dwarfism. Further research is warranted to test this association.
References
Eberth, John E., "Chondrodysplasia-Like Dwarfism in the Miniature Horse" (2013). Theses and Dissertations--Veterinary Science. 11
Eberth, John & Graves, Kathryn & MacLeod, J. & Bailey, Ernest. (2018). Multiple alleles of ACAN associated with chondrodysplastic dwarfism in Miniature horses. Animal Genetics. 49. 10.1111/age.12682
More Horse Health
Equine Recurrent Uveitis Risk and Severity
Equine Recurrent Uveitis (ERU) is the most common cause of blindness in horses, affecting about 3-15% of the horse population worldwide. Characterized by episodes of inflammation of the middle layer of the eye, Equine Recurrent Uveitis in horses leads to the development of cataracts, glaucoma and eventually complete loss of vision.
Foal Immunodeficiency Syndrome
Foal immunodeficiency syndrome (FIS) is a failure in the development of the adaptive immune system. At 3-6 weeks of age, once the maternal antibodies begin to degrade, foals exhibit signs of anemia, diarrhea, and pneumonia. As these foals fail to respond to treatment for infections, they are humanely euthanized at a young age.
Glanzmann Thrombasthenia
Glanzmann Thrombasthenia (GT) is a blood platelet function disorder, resulting from a reduction in the platelet fibrinogen receptor protein. Clinical signs can be characterized by bleeding on the skin or from the mouth/nostril/gastrointestinal mucosas, and may include skin rashes with blood spots under the skin, nasal bleeding, gastrointestinal and gingival bleedings.
Glycogen Branching Enzyme Deficiency
Glycogen Branching Enzyme Deficiency (GBED) is a lethal recessive disorder characterized by seizures, muscle weakness, respiratory failure, and death. Many affected foals do not make it full term and are aborted or stillborn. Carriers (gbed/n) have no known issues.